Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability

Yuqing Yan(Shanghai Jiao Tong University), Jie Hong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Muni Hu(Shanghai Jiao Tong University), Zhe Cui(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Lijun Ning(Shanghai Institute of Hematology), Zhenhua Wang(Anhui University of Traditional Chinese Medicine), Ying Zhao(Shanghai Jiao Tong University), Yanru Ma(Renji Hospital), Ziyun Gao(Nanchang University), Xiaowen Huang(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Tianying Tong(Shanghai Jiao Tong University), Yilu Zhou(Shanghai Jiao Tong University)
Cell Reports Medicine
August 1, 2023
10.1016/j.xcrm.2023.101153
Cited by 22

Related Papers

Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231
Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway
|PLoS ONE|2015|186
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183